• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Nanobac Pharmaceuticals Inc

+ Add to Watchlist

NNBP:US

0.0007 USD 0.0001 16.67%

As of 20:10:00 ET on 08/29/2014.

Snapshot for Nanobac Pharmaceuticals Inc (NNBP)

Open: 0.0006 Day's Range: 0.0006 - 0.0007 Volume: 203,600
Previous Close: 0.0006 52wk Range: 0.0003 - 0.0014 1-Yr Rtn: +1.82%

Stock Chart for NNBP

No chart data available.
  • NNBP:US 0.0007
  • 1D
  • 1M
  • 1Y
0.0006
Interactive NNBP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NNBP

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0346
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.17
Shares Outstanding (M) 249.51
30 Day Average Volume 32,587
Price/Book (mrq) -
Price/Sale (ttm) 9.7110
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NNBP

No data available

Company Profile & Key Executives for NNBP

Nanobac Pharmaceuticals, Inc. conducts pharmaceutical drug research and development, research and development of medical diagnostics, nanobiotechnology, and nanotechnology. The Company is developing medical therapeutics, such as NanobacTX, that eradicate disease associated with Nanobacterium sanguineum, a cause of atherosclerotic coronary artery calcified plaque.

John D StantonChairman/CEO/CFOBenedict ManiscalcoMedical Dir:Clinical Research
More Company Profile & Key Executives for NNBP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil